Diagnostic and prognostic value of IDH1 mutation in gliomas

Diagnostic and prognostic value of IDH1 mutation in gliomas

Objective To discuss the significance of IDH1 mutation for diagnosis and prognosis of gliomas through detecting of IDH1 mutation in supratentorial glioma cells. Methods IDH1 genes of postoperative pathological samples obtained from 315 patients with supratentorial gliomas (3 cases of WHO Ⅰ, 95 cases...

Full description

Bibliographic Details
Main Authors:	Yan⁃wu YANG, Fei XIE, Jun⁃jia TANG, Shuang LIU, Xiang WANG, Yan⁃hui LIU, Qing MAO
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2012-12-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	Genes Mutation Supratentorial neoplasms Diagnosis Glioma Prognosis
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/626

Similar Items

Research progress of IDH1 and IDH2 mutations in gliomas
by: Shan-shan ZHANG, et al.
Published: (2015-11-01)

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
by: Feng-Min Liu, et al.
Published: (2021-01-01)

Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report
by: Alexander H. C. W. Agopyan-Miu, et al.
Published: (2021-09-01)

Correlations of MGMT promoter methylation and IDH1 mutations with the clinical prognosis of malignant glioma patients
by: ZHANG Ning, MA Hui-hui, WANG Fan, LIANG Wei, WANG Yi-chun, WU Bing-shan, LI Qing-xin
Published: (2021-10-01)

Prognostic value of mutations in isocitrate dehydrogenase 1 (IDH1) and reverse telomerase transcriptase (TERT) in Argentine patients` gliomas
by: Pedro Tomás Funes, et al.
Published: (2021-03-01)

Influence of the depth of sedation on regional cerebral oxygen saturation monitoring in neurosurgery of supratentorial gliomas
by: Kai⁃ying ZHANG, et al.
Published: (2012-12-01)

MicroRNA as a potential diagnostic and prognostic biomarker in brain gliomas: a systematic review and meta-analysis
by: Fatemeh Hasani, et al.
Published: (2024-02-01)

Incidental Neuroradiological Findings with Magnetic Resonance Imaging of Brain and Spine: A Cross-sectional Study
by: Nida Heetawala, et al.
Published: (2021-11-01)

The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China
by: Guiquan Shen, et al.
Published: (2020-06-01)

Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma
by: Yanfei Jia, et al.
Published: (2021-01-01)

MR Imaging Findings of Supratentorial Meningeal Hemangioblastoma: A Case Report
by: Gi Hong Kim, et al.
Published: (2016-07-01)

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
by: Kanish Mirchia, et al.
Published: (2020-07-01)

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment
by: Jiarong He, et al.
Published: (2022-04-01)

Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases
by: Jiangfen Zhou, et al.
Published: (2022-08-01)

Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis
by: Yurong Li, et al.
Published: (2022-09-01)

Prognostic significance of HIF1-α immunohistochemical expression in gliomas and it's relation to IDH1 mutation status
by: Eman Ahmed Abd Elmaogod, et al.
Published: (2022-12-01)

Spatial distribution of supratentorial diffuse gliomas: A retrospective study of 990 cases
by: Gen Li, et al.
Published: (2023-01-01)

Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value
by: Hua-Bao Cai, et al.
Published: (2024-01-01)

SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values
by: Zhenyuan Han, et al.
Published: (2021-10-01)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
by: Georgios C. Manikis, et al.
Published: (2021-08-01)

<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01)

Combination of the Distance From Tumor Edge to Subventricular Zone and IDH Mutation Predicts Prognosis of Patients With Glioma
by: Shuixian Zhang, et al.
Published: (2021-08-01)

A Nomogram Modeling 11C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
by: Weiyan Zhou, et al.
Published: (2020-07-01)

Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence
by: Andreas Stadlbauer, et al.
Published: (2021-04-01)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
by: Jianing Wu, et al.
Published: (2022-05-01)

Prognostic and Predictive Biomarkers in Gliomas
by: Paulina Śledzińska, et al.
Published: (2021-09-01)

IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
by: Enrico Franceschi, et al.
Published: (2021-02-01)

Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
by: Gabrielle Metz, et al.
Published: (2022-01-01)

PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas
by: Yi Liu, et al.
Published: (2022-06-01)

Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection
by: Lidia Gatto, et al.
Published: (2024-01-01)

Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
by: Kang H, et al.
Published: (2020-10-01)

Sevoflurane versus PRopofol combined with Remifentanil anesthesia Impact on postoperative Neurologic function in supratentorial Gliomas (SPRING): protocol for a randomized controlled trial
by: Yan Xing, et al.
Published: (2020-05-01)

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
by: Zaoqu Liu, et al.
Published: (2021-07-01)

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
by: Leland G. Richardson, et al.
Published: (2020-01-01)

A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database
by: Amrit L. Pappula, et al.
Published: (2021-08-01)

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas
by: Akane Yamamichi, et al.
Published: (2016-01-01)

Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information
by: Lina Mörén, et al.
Published: (2015-09-01)

Analyses of metastasis-associated genes in IDH wild-type glioma
by: Xiaozhi Li, et al.
Published: (2020-11-01)

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype
by: Teresa Cejalvo, et al.
Published: (2020-11-01)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01)